ES2127259T3 - Sistema de liberacion prolongada de piribedil. - Google Patents

Sistema de liberacion prolongada de piribedil.

Info

Publication number
ES2127259T3
ES2127259T3 ES93401262T ES93401262T ES2127259T3 ES 2127259 T3 ES2127259 T3 ES 2127259T3 ES 93401262 T ES93401262 T ES 93401262T ES 93401262 T ES93401262 T ES 93401262T ES 2127259 T3 ES2127259 T3 ES 2127259T3
Authority
ES
Spain
Prior art keywords
piribedil
release system
prolonged release
ethylene
adhesive
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93401262T
Other languages
English (en)
Inventor
Alain Cuine
Isabelle Rault
Francoise Arnaud
Olivier Crambes
Gerald Pichon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ADIR SARL
Original Assignee
ADIR SARL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ADIR SARL filed Critical ADIR SARL
Application granted granted Critical
Publication of ES2127259T3 publication Critical patent/ES2127259T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Addiction (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Absorbent Articles And Supports Therefor (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Materials For Medical Uses (AREA)

Abstract

LA INVENCION CONCIERNE A UN SISTEMA MATRICIAL COMPUESTO DE COPOLIMERO DE ETILENO/ACETATO DE VINILO, AUTOADHESIVO PARA LA LIBERACION PROLONGADA DEL PIRIBEDIL. ESTE SISTEMA ASEGURA LA DIFUSION CONTINUA Y REGULAR DEL PIRIBEDIL POR VIA TRANSCUTANEA.
ES93401262T 1992-05-19 1993-05-18 Sistema de liberacion prolongada de piribedil. Expired - Lifetime ES2127259T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9206037A FR2691361B1 (fr) 1992-05-19 1992-05-19 Systeme matriciel autoadhesif pour la liberation prolongee du piribedil par voie transcutanee.

Publications (1)

Publication Number Publication Date
ES2127259T3 true ES2127259T3 (es) 1999-04-16

Family

ID=9429912

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93401262T Expired - Lifetime ES2127259T3 (es) 1992-05-19 1993-05-18 Sistema de liberacion prolongada de piribedil.

Country Status (11)

Country Link
EP (1) EP0571264B1 (es)
JP (1) JPH0632738A (es)
AT (1) ATE173623T1 (es)
AU (1) AU656266B2 (es)
CA (1) CA2096511A1 (es)
DE (1) DE69322201T2 (es)
DK (1) DK0571264T3 (es)
ES (1) ES2127259T3 (es)
FR (1) FR2691361B1 (es)
NZ (1) NZ247648A (es)
ZA (1) ZA933508B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2675383B1 (fr) * 1991-04-18 1995-05-12 Bernard Aranda Utilisation d'un medicament pour la fabrication d'un medicament destine au traitement des vessies hyperactives ou instables.
US5840327A (en) * 1995-08-21 1998-11-24 Alza Corporation Transdermal drug delivery device having enhanced adhesion
FR2744130B1 (fr) * 1996-01-31 1998-03-20 Atohaas Holding Cv Composition adhesive pour materiaux en (co) polymere (meth) acrylique
CN103373991A (zh) * 2013-07-12 2013-10-30 安徽安腾药业有限责任公司 高纯度、高收率制备吡贝地尔的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2355502A1 (fr) * 1976-06-23 1978-01-20 Roussel Uclaf Application a titre de medicaments d'un derive de la piperazine et de ses sels
ATE109357T1 (de) * 1988-02-26 1994-08-15 Riker Laboratories Inc Transdermales estradiol als therapeutisches sytem.
FR2664815B1 (fr) * 1990-07-23 1994-11-04 Adir Systeme matriciel autoadhesif pour la liberation prolongee du piribedil par voie transcutanee.
GB9102089D0 (en) * 1991-01-31 1991-03-13 Johnson & Johnson Medical Net wound dressings

Also Published As

Publication number Publication date
ZA933508B (en) 1993-12-10
AU656266B2 (en) 1995-01-27
JPH0632738A (ja) 1994-02-08
ATE173623T1 (de) 1998-12-15
AU3860793A (en) 1993-11-25
FR2691361B1 (fr) 1994-07-08
DK0571264T3 (da) 1999-08-09
EP0571264B1 (fr) 1998-11-25
NZ247648A (en) 1995-01-27
EP0571264A1 (fr) 1993-11-24
CA2096511A1 (fr) 1993-11-20
DE69322201T2 (de) 1999-06-24
DE69322201D1 (de) 1999-01-07
FR2691361A1 (fr) 1993-11-26

Similar Documents

Publication Publication Date Title
FI954989A (fi) Lääkelaastari
DE69300046D1 (de) Traktionssteuerungssystem.
DE68919641T2 (de) Halbduplex-Lautfernsprecher.
IT1239266B (it) Sistema di chiamata di emergenza di gruppo.
MX9205998A (es) Sistema automatico para la distribucion de llamadas telefonicas.
DE68908215D1 (de) Einrichtungen und systeme, basierend auf supraleitenden materialien.
FI892753A0 (fi) Hoejdregleringsanordning foer armstoed pao stolar, saerskilt rullstolar.
FI860922A0 (fi) Automatpress foer applicering av tryckknappsdelar pao en baerare, t.ex.klaedstycken.
DK15789A (da) Azolsubstituerede cycloalkanolderivater, fremgangsmaade til fremstilling deraf samt anvendelse af derivaterne som landbrugs- og havebrugsfungicider.
ES2127259T3 (es) Sistema de liberacion prolongada de piribedil.
DE69102371D1 (de) Abgasreinigungsvorrichtung.
ES2075942T3 (es) Sistema matricial autoadhesivo para la liberacion prolongada de pirebidil.
FI895742A0 (fi) Pao mineralfibrer baserad blandmaterial, anordning foer dess tillverkning och tillaempning av blandmaterialet.
FI883855A (fi) Foerfarande och koppling foer automatisk, pao en raeknare baserad reglering av frekvensen i en radiotelefon.
ES2131518T3 (es) Sistema de expresion eucariota.
FI101855B1 (fi) Menetelmä asetatsolamidia jatkuvasti vapauttavan asetatsolamidivalmisteen valmistamiseksi
FI905872A0 (fi) Pelare foer uppbaerning av en platta, saosom en balkongplatta, pao en vaegg.
IL98544A0 (en) Oxido reductase enzyme system obtainable from p.chrysogenum,its preparation and its use
FR2691868B3 (fr) Amplificateur sélectif, principalement pour malentendants.
ES1029889Y (es) Baliza aerostatica perfeccionada.
MX9102641A (es) Sistema de orificios.
ITMI951965A0 (it) Dispositivo di aggancio/sgancio automatico per passeggini carrozzine e simili
ES1022793Y (es) Peana dotada de dispositivo sonoro, para trofeos.
FR2700057B1 (fr) Système électro-pneumatique.
IT8819176A0 (it) Dispositivo per la distribuzione automatica di oggetti, particolarmente di giornali osimili.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 571264

Country of ref document: ES